Condition
Molecular Mechanisms of Pharmacological Action clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Molecular Mechanisms of Pharmacological Action clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Canada (1), Poland (1)). By phase: Phase 4 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Molecular Mechanisms of Pharmacological Action clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients | — | Milan, MI | Recruiting | Aug 2, 2024 |
| Testing a new drug for treatment-resistant depression | Phase 2 | Bethesda, Maryland | Recruiting | Jul 22, 2024 |
| Understanding the impact of mood disorders and treatment responses | — | Bethesda, Maryland | Recruiting | Jun 17, 2024 |
| Using Sacubitril/Valsartan to prevent heart damage in breast cancer treatment | Phase 4 | Opole, Opole Voivodeship and 3 other locations | Recruiting | Jul 19, 2022 |
| Effects of Dexmedetomidine on cognitive recovery after cardiac surgery | Phase 4 | Vancouver, British Columbia and 7 other locations | Recruiting | Feb 28, 2020 |
All recruiting trials (5)
-
Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients
This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.
-
Testing a new drug for treatment-resistant depression
This study is testing a new drug called HNK to see if it can help people with treatment-resistant depression feel better when other medications haven't worked.
-
Understanding the impact of mood disorders and treatment responses
This study is trying to learn more about how people with depression and bipolar disorder respond to treatment by talking to them weekly for up to 12 weeks to improve future care and predict how well medications might work.
-
Using Sacubitril/Valsartan to prevent heart damage in breast cancer treatment
This study is testing if the medication Sacubitril/Valsartan can help protect the hearts of women undergoing treatment for breast cancer from damage.
-
Effects of Dexmedetomidine on cognitive recovery after cardiac surgery
This study is testing if a medication called Dexmedetomidine can help people recover their thinking skills better after having heart surgery.
Related topics
Quick answers
How many Molecular Mechanisms of Pharmacological Action clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Canada (1 trial), Poland (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.